+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report by Type (Complete Blood Count, HGB/HCT Testing), End-use (Primary Clinics, Central Laboratories), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 104 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5004004
Description Jump to:
The global clinical laboratory tests market size is expected to reach USD 213.04 billion by 2030, expanding at a CAGR of 9.2% from 2024 to 2030. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights

  • HbA1c tests segment held largest revenue share in 2023 and is attributable to the increasing prevalence of diabetic population
  • HGB/HCT tests segment is expected to show fastest growth rate over the forecast period owing to the growing prevalence of blood-related disorders
  • Central laboratories segment dominated the market in 2023 attributable to the high market penetration and procedure volumes
  • North America held the largest market share in 2023 which can be attributed to the growing regulatory support and increase in investments in clinical laboratory tests

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia-Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing geriatric population
3.2.1.2. Growing prevalence of target disease
3.2.1.3. Introduction of innovative solutions
3.2.2. Market restraint analysis
3.2.2.1. Presence of ambiguous regulatory framework
3.2.2.2. COVID-19 pandemic
3.3. Clinical Laboratory Tests Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Clinical Laboratory Tests Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Complete Blood Count
4.4.1.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.2. HGB/HCT Testing
4.4.2.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.3. Basic Metabolic Panel Testing
4.4.3.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.4. BUN Creatinine Testing
4.4.4.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.5. Electrolytes Testing
4.4.5.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.6. HbA1c Testing
4.4.7. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.8. Comprehensive Metabolic Panel Testing
4.4.8.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9. Liver Panel Testing
4.4.9.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.2. Hepatitis
4.4.9.2.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.3. Bile Duct Obstruction
4.4.9.3.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.4. Liver Cirrhosis
4.4.9.4.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.5. Liver Cancer
4.4.9.5.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.6. Bone Disease
4.4.9.6.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.7. Autoimmune Disorders
4.4.9.7.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.9.8. Others
4.4.9.8.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.10. Renal Panel Testing
4.4.10.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.11. Lipid Panel Testing
4.4.11.1. Market estimates and forecasts, 2018-2030 (USD Billion)
4.4.12. Cardiovascular Panel Testing
4.4.12.1. Market estimates and forecasts, 2018-2030 (USD Billion)
Chapter 5. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Clinical Laboratory Tests Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Central Laboratories
5.4.1.1. Market estimates and forecasts, 2018-2030 (USD Billion)
5.4.2. Primary Clinics
5.4.2.1. Market estimates and forecasts, 2018-2030 (USD Billion)
Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018-2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts, 2018-2030 (USD Billion)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts, 2018-2030 (USD Billion)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts, 2018-2030 (USD Billion)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts, 2018-2030 (USD Billion)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts, 2018-2030 (USD Billion)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts, 2018-2030 (USD Billion)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts, 2018-2030 (USD Billion)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts, 2018-2030 (USD Billion)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts, 2018-2030 (USD Billion)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts, 2018-2030 (USD Billion)
6.7. Asia-Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts, 2018-2030 (USD Billion)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts, 2018-2030 (USD Billion)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts, 2018-2030 (USD Billion)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts, 2018-2030 (USD Billion)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts, 2018-2030 (USD Billion)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts, 2018-2030 (USD Billion)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts, 2018-2030 (USD Billion)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts, 2018-2030 (USD Billion)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts, 2018-2030 (USD Billion)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts, 2018-2030 (USD Billion)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts, 2018-2030 (USD Billion)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts, 2018-2030 (USD Billion)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts, 2018-2030 (USD Billion)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. CINVEN
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. QUEST DIAGNOSTICS INCORPORATED
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. OPKO HEALTH, INC.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. F. Laboratory Corporation of America Holdings
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. UNILABS
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Synnovis Group LLP
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. SONIC HEALTHCARE
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America clinical laboratory tests market, by region, 2018-2030 (USD Billion)
Table 3 North America clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 4 North America clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 5 U.S. clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 6 U.S. clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 7 Canada clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 8 Canada clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 9 Europe clinical laboratory tests market, by region, 2018-2030 (USD Billion)
Table 10 Europe clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 11 Europe clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 12 Germany clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 13 Germany clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 14 UK clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 15 UK clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 16 France clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 17 France clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 18 Italy clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 19 Italy clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 20 Spain clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 21 Spain clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 22 Denmark clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 23 Denmark clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 24 Sweden clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 25 Sweden clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 26 Norway clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 27 Norway clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 28 Asia-Pacific clinical laboratory tests market, by region, 2018-2030 (USD Billion)
Table 29 Asia-Pacific clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 30 Asia-Pacific clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 31 China clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 32 China clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 33 Japan clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 34 Japan clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 35 India clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 36 India clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 37 South Korea clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 38 South Korea clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 39 Australia clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 40 Australia clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 41 Thailand clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 42 Thailand clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 43 Latin America clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 44 Latin America clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 45 Latin America clinical laboratory tests market, by application, 2018-2030 (USD Billion)
Table 46 Brazil clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 47 Brazil clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 48 Mexico clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 49 Mexico clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 50 Argentina clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 51 Argentina clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 52 MEA clinical laboratory tests market, by region, 2018-2030 (USD Billion)
Table 53 MEA clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 54 MEA clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 55 South Africa clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 56 South Africa clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 57 Saudi Arabia clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 58 Saudi Arabia clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 59 UAE clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 60 UAE clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
Table 61 Kuwait clinical laboratory tests market, by type, 2018-2030 (USD Billion)
Table 62 Kuwait clinical laboratory tests market, by end-use, 2018-2030 (USD Billion)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Clinical laboratory tests market: market outlook
Figure 14 Clinical laboratory tests competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Clinical laboratory tests market driver impact
Figure 20 Clinical laboratory tests market restraint impact
Figure 21 Clinical laboratory tests market strategic initiatives analysis
Figure 22 Clinical laboratory tests market: Type movement analysis
Figure 23 Clinical laboratory tests market: Type outlook and key takeaways
Figure 24 CBC market estimates and forecast, 2018-2030
Figure 25 HGB/HCT test market estimates and forecast, 2018-2030
Figure 26 Basic metabolic panel market estimates and forecast, 2018-2030
Figure 27 BUN creatinine test market estimates and forecast, 2018-2030
Figure 28 Electrolyte tests market estimates and forecast, 2018-2030
Figure 29 HbA1c tests market estimates and forecast, 2018-2030
Figure 30 Comprehensive metabolic panel market estimates and forecast, 2018-2030
Figure 31 Liver panel test market estimates and forecast, 2018-2030
Figure 32 Hepatitis liver panel tests market estimates and forecast, 2018-2030
Figure 33 Bile duct obstruction liver panel tests market estimates and forecast, 2018-2030
Figure 34 Liver cirrhosis liver panel tests market estimates and forecast, 2018-2030
Figure 35 Liver cancer liver panel tests market estimates and forecast, 2018-2030
Figure 36 Bone disease liver panel tests market estimates and forecast, 2018-2030
Figure 37 Autoimmune disorders liver panel tests market estimates and forecast, 2018-2030
Figure 38 Others liver panel tests market estimates and forecast, 2018-2030
Figure 39 Renal panel test market estimates and forecast, 2018-2030
Figure 40 Lipid panel tests market estimates and forecast, 2018-2030
Figure 41 Cardiovascular panel test market estimates and forecast, 2018-2030
Figure 42 Clinical laboratory tests market: End-use movement Analysis
Figure 43 Clinical laboratory tests market: End-use outlook and key takeaways
Figure 44 Central Laboratories market estimates and forecasts, 2018-2030
Figure 45 Primary Clinics market estimates and forecasts,2018-2030
Figure 46 Global clinical laboratory tests market: Regional movement analysis
Figure 47 Global clinical laboratory tests market: Regional outlook and key takeaways
Figure 48 Global clinical laboratory tests market share and leading players
Figure 49 North America market share and leading players
Figure 50 Europe market share and leading players
Figure 51 Asia-Pacific market share and leading players
Figure 52 Latin America market share and leading players
Figure 53 Middle East & Africa market share and leading players
Figure 54 North America: SWOT
Figure 55 Europe SWOT
Figure 56 Asia-Pacific SWOT
Figure 57 Latin America SWOT
Figure 58 MEA SWOT
Figure 59 North America, by country
Figure 60 North America
Figure 61 North America market estimates and forecasts, 2018-2030
Figure 62 U.S.
Figure 63 U.S. market estimates and forecasts, 2018-2030
Figure 64 Canada
Figure 65 Canada market estimates and forecasts, 2018-2030
Figure 66 Europe
Figure 67 Europe market estimates and forecasts, 2018-2030
Figure 68 UK
Figure 69 UK market estimates and forecasts, 2018-2030
Figure 70 Germany
Figure 71 Germany market estimates and forecasts, 2018-2030
Figure 72 France
Figure 73 France market estimates and forecasts, 2018-2030
Figure 74 Italy
Figure 75 Italy market estimates and forecasts, 2018-2030
Figure 76 Spain
Figure 77 Spain market estimates and forecasts, 2018-2030
Figure 78 Denmark
Figure 79 Denmark market estimates and forecasts, 2018-2030
Figure 80 Sweden
Figure 81 Sweden market estimates and forecasts, 2018-2030
Figure 82 Norway
Figure 83 Norway market estimates and forecasts, 2018-2030
Figure 84 Asia-Pacific
Figure 85 Asia-Pacific market estimates and forecasts, 2018-2030
Figure 86 China
Figure 87 China market estimates and forecasts, 2018-2030
Figure 88 Japan
Figure 89 Japan market estimates and forecasts, 2018-2030
Figure 90 India
Figure 91 India market estimates and forecasts, 2018-2030
Figure 92 Thailand
Figure 93 Thailand market estimates and forecasts, 2018-2030
Figure 94 South Korea
Figure 95 South Korea market estimates and forecasts, 2018-2030
Figure 96 Australia
Figure 97 Australia market estimates and forecasts, 2018-2030
Figure 98 Latin America
Figure 99 Latin America market estimates and forecasts, 2018-2030
Figure 100 Brazil
Figure 101 Brazil market estimates and forecasts, 2018-2030
Figure 102 Mexico
Figure 103 Mexico market estimates and forecasts, 2018-2030
Figure 104 Argentina
Figure 105 Argentina market estimates and forecasts, 2018-2030
Figure 106 Middle East and Africa
Figure 107 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 108 South Africa
Figure 109 South Africa market estimates and forecasts, 2018-2030
Figure 110 Saudi Arabia
Figure 111 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 112 UAE
Figure 113 UAE market estimates and forecasts, 2018-2030
Figure 114 Kuwait
Figure 115 Kuwait market estimates and forecasts, 2018-2030
Figure 116 Market share of key market players- Clinical laboratory tests market

Companies Mentioned

  • Abbott
  • CINVEN
  • QUEST DIAGNOSTICS INCORPORATED
  • OPKO HEALTH, INC.
  • F. Laboratory Corporation of America Holdings
  • UNILABS
  • Synnovis Group LLP
  • SONIC HEALTHCARE

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages104
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 114.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 213.04 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Laboratory Services Market Size, Share & Trends Analysis Report By Test Type (Human & Tumor Genetics, Clinical Chemistry), By Service Provider, By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Clinical Laboratory Tests Market by Test Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Clinical Laboratory Tests Market by Test Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
The Worldwide Market for Clinical Laboratory Services, 9th Edition - Product Image

The Worldwide Market for Clinical Laboratory Services, 9th Edition

  • Report
  • 250 Pages
  • Global
From
Laboratory Proficiency Testing Market by Technology, Application, End-Use - Global Forecast 2025-2030 - Product Image

Laboratory Proficiency Testing Market by Technology, Application, End-Use - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.